col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: Avens Publishing Group

26 Results       Page 1

 [1] 
  original article Journal Date Title Authors All Authors
1 [GO] Journal of Hematology & Thrombosis 2022―Dec―05 Survival of Patients with Hematologic Malignancies and Covid-19 BL Gilberto
2 [GO] Journal of Addiction & Prevention 2022―Dec―05 Change in Patterns of Tobacco Use during Lockdown due to COVID-19 B Yukti
3 [GO] Journal of Neurology and Psychology 2022―Dec―05 Investigation of the Effect of the Fear of COVID-19 on School Refusal in terms of Depression, Anxiety, Social Functioning and Academic Resilience K Karaca
4 [GO] Journal of Neurology and Psychology 2022―Dec―05 Investigation of the Effect of the Fear of COVID-19 on School Refusal in terms of Depression, Anxiety, Social Functioning and Academic Resilience K Karaca
5 [GO] International Journal of Otorhinolaryngology 2022―Dec―05 Rhino-pulmonary Mucormycosis in Post COVID-19 patient K Nagi
6 [GO] International Journal of Otorhinolaryngology 2022―Dec―05 Facial Nerve Palsy Associated With Covid-19; a Case Report S Motamed
7 [GO] Journal of Oral Biology 2022―Oct―14 Awareness, Challenges and Impact of COVID-19 Lockdown: Orthodontic Patient’s Perspective AA Jain
8 [GO] Journal of Oral Biology 2022―Oct―14 Effect of COVID-19 Pandemic on Clinic Attendance and Management of Dental Patients: Our Experience at Dental Hospital, Obafemi Awolowo University Teaching Hospitals’ Complex, Ile Ife, Nigeria EO Oyetola
9 [GO] Journal of Geriatrics and Palliative Care 2021―Dec―21 COVID-19 Vaccination with Special Reference to Adenoviral Vectors, Clotting Disorders and Old Age SV Jargin
10 [GO] Journal of Surgery 2021―May―20 General Surgery during Pandemic Era - Evolving Strategies: A Cohort Study from a Tertiary Care Centre in North India R Wadhawan
11 [GO] Journal of Pharmaceutics & Pharmacology 2021―Mar―08 Potential for the Use of Adamantanes for the Prevention and Treatment of the Neurological Complications of COVID-19 Roger F Butterworth
12 [GO] Journal of Pharmaceutics & Pharmacology 2021―Mar―08 Potential for the Repurposing of Adamantanes for the Treatment of Covid-19 Roger F Butterworth
13 [GO] Journal of Pharmaceutics & Pharmacology 2021―Mar―08 Repurposing of Adamantanes with Transmitter Receptor Antagonist Properties for the Prevention/Treatment of COVID-19 SR Brenner
14 [GO] Journal of Pharmaceutics & Pharmacology 2021―Mar―08 Lysosomotropic Action of Amantadine: Basis for Treatment of COVID-19 SP Smieszek
15 [GO] Journal of Pharmaceutics & Pharmacology 2021―Mar―08 Adamantanes for the Prevention of COVID-19: A Review of Case Reports Cortes A Borra
16 [GO] Journal of Pharmaceutics & Pharmacology 2021―Mar―08 Repurposing of Adamantanes for the Treatment of COVID-19: Rationale and Perspectives Roger F Butterworth
17 [GO] Journal of Pharmaceutics & Pharmacology 2021―Mar―08 The Sars-Cov-2 Viroporin E and its Interaction with Amantadine an Analysis Aranda Abreu GE
18 [GO] Journal of Pharmaceutics & Pharmacology 2021―Mar―08 Amantadine for the Treatment of SARS-Cov-2: Case Report GE Aranda-Abreu
19 [GO] Journal of Pharmaceutics & Pharmacology 2020―Dec―07 Lysosomotropic Action of Amantadine: Basis for Treatment of COVID-19
20 [GO] Journal of Pharmaceutics & Pharmacology 2020―Dec―07 Potential for the Use of Adamantanes for the Prevention and Treatment of the Neurological Complications of COVID-19
21 [GO] Journal of Pharmaceutics & Pharmacology 2020―Dec―07 Adamantanes for the Prevention of COVID-19: A Review of Case Reports
22 [GO] Journal of Pharmaceutics & Pharmacology 2020―Dec―07 Repurposing of Adamantanes for the Treatment of COVID-19: Rationale and Perspectives
23 [GO] Journal of Pharmaceutics & Pharmacology 2020―Dec―07 The Sars-Cov-2 Viroporin E and its Interaction with Amantadine an Analysis
24 [GO] Journal of Pharmaceutics & Pharmacology 2020―Dec―07 Amantadine for the Treatment of SARS-Cov-2: Case Report
25 [GO] Journal of Oral Biology 2020―Dec―05 pH, Presents a New Weapon in the Battle Against COVID-19
26 [GO] Journal of Parkinson’s Disease and Alzheimer’s Disease 2020―Dec―05 Amantadine Treatment for Parkinson’s Disease during COVID-19: Bimodal Action Targeting Viral Replication and the NMDA Receptor
 [1] 

26 Results       Page 1




[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.021 sec